Norris Perne & French LLP MI Sells 11,054 Shares of Danaher Corporation $DHR

Norris Perne & French LLP MI lowered its position in shares of Danaher Corporation (NYSE:DHR) by 12.7% in the third quarter, Holdings Channel reports. The institutional investor owned 76,056 shares of the conglomerate’s stock after selling 11,054 shares during the period. Norris Perne & French LLP MI’s holdings in Danaher were worth $15,079,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of DHR. WFA of San Diego LLC bought a new position in Danaher during the second quarter worth about $26,000. Howard Hughes Medical Institute bought a new stake in Danaher in the 2nd quarter valued at about $27,000. Red Tortoise LLC grew its position in shares of Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares in the last quarter. Heartwood Wealth Advisors LLC bought a new position in shares of Danaher during the third quarter worth approximately $37,000. Finally, Ramirez Asset Management Inc. bought a new position in shares of Danaher during the second quarter worth approximately $40,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Danaher stock opened at $230.52 on Monday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23. The stock has a market capitalization of $162.83 billion, a P/E ratio of 47.53, a price-to-earnings-growth ratio of 4.45 and a beta of 0.89. The stock has a fifty day moving average of $222.66 and a 200-day moving average of $208.22.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.17. The business had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.Danaher’s revenue was up 4.4% compared to the same quarter last year. During the same period last year, the firm posted $1.71 earnings per share. On average, sell-side analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be issued a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, December 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s payout ratio is 26.39%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a research note on Monday, December 22nd. Barclays lifted their price objective on Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Robert W. Baird set a $247.00 target price on Danaher in a report on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft raised their price target on Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Finally, Bank of America cut their price objective on shares of Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research report on Monday, September 22nd. Twenty-one equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $248.25.

Insider Buying and Selling

In related news, Director Teri List sold 3,298 shares of the stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the transaction, the director owned 20,762 shares of the company’s stock, valued at $4,702,593. This represents a 13.71% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Brian W. Ellis sold 21,776 shares of the firm’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the completion of the sale, the senior vice president owned 14,553 shares in the company, valued at $3,190,454.19. This represents a 59.94% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 30,248 shares of company stock worth $6,609,663 in the last three months. 11.20% of the stock is owned by corporate insiders.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.